Kikuchi-Fujimoto disease and COVID-19. Case report

Authors

Keywords:

histiocytic necrotizing lymphadenitis, coronavirus infections, Covid-19

Abstract

Introduction: Kikuchi-Fujimoto disease is considered a necrotizing histiocytic lymphadenitis of infrequent presentation. Its diagnosis is anatomopathological. In the current global context of the COVID-19 pandemic, this viral disease ranges from an asymptomatic condition to severe pneumonia, in addition to other atypical presentations.
Patient information: white female, 34 years old, with health history and no toxic habits, who presented with fever between 38 and 390C, once or twice a day, without chills, which decreased with the administration of antipyretics. After the first 13 days of the onset of symptoms, the fever disappeared for six days and then reappeared with the same characteristics; for this reason it was decided to admit her to the hospital. The diagnosis of Kikuchi-Fujimoto disease was obtained after several complementary tests.
Conclusions: the report of this case could announce the possible location of the new SARS-CoV-2 coronavirus among the etiologies of EKF.

Downloads

Download data is not yet available.

Author Biographies

Dianelí Lorely Reyes Hernández, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Especialista en II Grado en Medicina Interna. Profesora Auxiliar en la Universidad de Ciencias Médicas de Villa Clara. Investigadora agregada.

Emanuel Ravelo Iglesias, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Residente de Medicina Interna

Daniel Artiles Martínez, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Especialista en I Grado en Medicina General Integral. Especialista en I Grado en Anatomía Patológica. Máster en Citopatología. Profesor Asistente en la Universidad de Ciencias Médicas de Villa Clara.

References

1.Aguado Navarro M, Sagristá González M. Linfadenitis histiocítica necrotizante o enfermedad de Kikuchi-Fujimoto. Med Fam Andal [Internet]. 2018 [citado 18/09/2021];19(2):180-181. Disponible en: https://www.samfyc.es/wp-content/uploads/2019/01/v19n2_10_cartaLinfadenitis.pdf

2.Singh JM, Shermetaro CB. Kikuchi-Fujimoto disease in Michigan: a rare case report and review of the literature. Clin Med Insights Ear Nose Throat [Internet]. 2019 [citado 18/09/2021];12:1179550619828680. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393831/. https://dx.doi.org/10.1177/1179550619828680

3.Joean O, Thiele T, Raap M, Schmidt RE, Stoll M. Take a second look: it’s Kikuchi’s disease! A case report and review of literature. Clin Pract [Internet]. 2018 [citado 18/09/2021];8(4):1095. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297864/. https://dx.doi.org/10.4081/cp.2018.1095

4.Almeida Esquivel Y, Piñón García K, Creagh García J. Enfermedad de Kikuchi-Fujimoto. Rev Ciencias Médicas [Internet]. 2021 Jul-Ago [citado 27/09/2021];25(1):e4563. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942021000100020

5.Lugo López JI, Garduño Mejía JE, Hernández Nava M. Enfermedad de Kikuchi-Fujimoto (linfadenitis histiocítica necrosante). Caso clínico más revisión bibliográfica. Rev Mex Cir Bucal Maxilofac [Internet]. 2019 [citado 27/09/2021];15(1):5-12. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=86141

6.Jaseb K, Nameh Goshay Fard N, Rezaei N, Sadeghian S, Sadeghian S. COVID-19 in a case with Kikuchi-Fujimoto disease. Clin Case Rep [Internet]. 2021 [citado 18/09/2021];9(3):1279-1282. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981657/. https://dx.doi.org/10.1002/ccr3.3748

7.Racette SD, Alexiev BA, Angarone MP, Bhasin A, Lima K, Jennings LJ, et al. Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report. BMC Infect Dis [Internet]. 2021 [citado 18/09/2021];21(1):740. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329643/. https://dx.doi.org/10.1186/s12879-021-06048-0

8.Capó de Paz V, Borrajero Martínez I, Montero González T, Hurtado de Mendoza Amat J, de Armas Rodríguez Y, Domínguez Alvarez C. Hallazgos de autopsias de 50 fallecidos con SARS-CoV-2 en Cuba entre abril y septiembre de 2020. Anales de la ACC [Internet]. 2021 [citado 20/09/2021];11(2):e860. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2304-01062021000200024

9.Comino-Trinidad O, Calvo A, Ojeda A, Mercadal J, Cornellas L, Ferrando C. Coagulación intravascular diseminada como forma de presentación de la enfermedad por coronavirus-19. Caso clínico. Rev Esp Anestesiol Reanim [Internet]. 2021 [citado 21/09/2021];68(1):41-45. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247485/. https://dx.doi.org/10.1016/j.redar.2020.05.010

10.Asuar Geisselmann I, Martínez Torre S, Gómez Molinero I, Morales Calahorro E, Larumbe Milla S. Formas atípicas de presentación de la enfermedad COVID-19 observadas en atención primaria. FMC [Internet]. 2020 [citado 21/09/2021];27(9):469-475. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682426/. https://dx.doi.org/10.1016/j.fmc.2020.06.002

11.Gil R, Bitar P, Deza C, Dreyse J, Florenzano M, Ibarra C, et al. Cuadro Clínico del COVID-19. Rev Méd Clín Las Condes [Internet]. 2021 [citado 21/09/2021];32(1):20-29. Disponible en: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-cuadro-clinico-del-covid-19-S0716864020300912. http://doi.org/10.1016/j.rmclc.2020.11.004

12.González González F, Cortés Correa C, Penaranda Contreras E. Manifestaciones cutáneas en pacientes con COVID-19: características clínicas y mecanismos fisiopatológicos postulados. Actas Dermosifiliogr [Internet]. 2021 [citado 27/09/2021];112(4):314-23. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698822/. https://dx.doi.org/10.1016/j.ad.2020.11.013

13.Sánchez Linares V, Nieda Rosales L, Martínez Cuervo J. Manifestaciones cutáneas de Covid-19. Gac Méd Espirituana [Internet]. 2020 [citado 27/09/2021];22(3):18-26. Disponible en: http://revgmespirituana.sld.cu/index.php/gme/article/view/2201/pdf

14.Ministerio de Salud Pública de Cuba. Protocolo de manejo clínico de COVID-19: versión 1.6 Ferbrero) [Internet]. La Habana: MINSAP; 2021 [citado 27/09/2021]. Disponible en: https://covid19cubadata.github.io/protocolos/protocolo-version-6.pdf

Downloads

Published

2021-11-25

How to Cite

1.
Reyes Hernández DL, Ravelo Iglesias E, Artiles Martínez D. Kikuchi-Fujimoto disease and COVID-19. Case report. Acta Méd Centro [Internet]. 2021 Nov. 25 [cited 2026 Jan. 12];16(1):150-7. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1567

Issue

Vol. 16 No. 1 (2022): January-March

Section

Case Reports

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).